Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Inspira Technologies Oxy BHN ( (IINN) ) is now available.
On April 1, 2026, Inspira Technologies Oxy B.H.N. Ltd. signed an asset purchase agreement with Nano Dimension Technologies Ltd. to acquire the latter’s additive manufacturing electronics business and Fabrica business, with the transaction closing on April 6, 2026. The deal, valued at up to $12.5 million including a $2 million cash payment at closing and up to $10.5 million in performance-based deferred consideration over 12 months, transfers intellectual property, equipment, customer contracts, facilities, and related commercial operations, giving Inspira immediate control over a high-precision 3D electronic printing platform suited for next-generation, high-value electronic applications.
The acquisition of Nano Dimension’s AME platform, which includes multi-material additive manufacturing technology capable of printing 3D electronic layers with micro-scale precision, is intended to support the next stage of Inspira’s strategy by redirecting proven manufacturing infrastructure and engineering capabilities toward high-value uses. Inspira has clarified that its existing medical device operations will be placed into a wholly owned subsidiary and will continue independently, suggesting a strategic broadening of the company’s focus while maintaining its core MedTech business for stakeholders.
The most recent analyst rating on (IINN) stock is a Hold with a $0.46 price target. To see the full list of analyst forecasts on Inspira Technologies Oxy BHN stock, see the IINN Stock Forecast page.
Spark’s Take on IINN Stock
According to Spark, TipRanks’ AI Analyst, IINN is a Neutral.
The score is driven primarily by very weak financial performance (minimal/unstable revenue, sustained losses, and heavy cash burn) and bearish technical conditions (price below all key moving averages with negative MACD). Valuation provides limited support because the company is loss-making (negative P/E) and offers no dividend yield.
To see Spark’s full report on IINN stock, click here.
More about Inspira Technologies Oxy BHN
Inspira Technologies OXY B.H.N. Ltd. is a commercial-stage medical device company specializing in advanced respiratory support and real-time blood monitoring solutions. Its portfolio includes the FDA-cleared INSPIRA ART100 system for cardiopulmonary bypass in the U.S. and ECMO procedures outside the U.S., the next-generation INSPIRA ART500 for awake, spontaneously breathing patients, and the HYLA blood sensor platform, positioning the firm within the life-support and MedTech landscape.
Average Trading Volume: 616,462
Technical Sentiment Signal: Sell
Current Market Cap: $20.87M
Find detailed analytics on IINN stock on TipRanks’ Stock Analysis page.